Skip to main content

Lifecore Biomedical, Inc. DE

LFCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001005286

No open-market purchases or sales by Lifecore Biomedical, Inc. DE insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Lifecore Biomedical, Inc. DE as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
98
−5 vs. Q1 2026
Shares held
25.4M
+297.6K (+1.2%) vs. Q1 2026
Total value
$133.3M
+$39.9M (+42.7%) vs. Q1 2026
New holders
14
35 more added
Sold out
19
22 more reduced

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LFCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 98 institutions
Q1 2021: 93 institutionsQ2 2021: 95 institutionsQ3 2021: 92 institutionsQ4 2021: 98 institutionsQ1 2022: 97 institutionsQ2 2022: 90 institutionsQ3 2022: 86 institutionsQ4 2022: 93 institutionsQ1 2023: 82 institutionsQ2 2023: 75 institutionsQ3 2023: 69 institutionsQ4 2023: 78 institutionsQ1 2024: 79 institutionsQ2 2024: 75 institutionsQ3 2024: 82 institutionsQ4 2024: 76 institutionsQ1 2025: 87 institutionsQ2 2025: 87 institutionsQ3 2025: 100 institutionsQ4 2025: 104 institutionsQ1 2026: 105 institutionsQ2 2026: 98 institutions
Value heldQ2 2026: $133.3M
Q1 2021: $275.2MQ2 2021: $285.5MQ3 2021: $235.5MQ4 2021: $287.2MQ1 2022: $278.9MQ2 2022: $252.1MQ3 2022: $220.0MQ4 2022: $160.0MQ1 2023: $81.7MQ2 2023: $173.9MQ3 2023: $132.5MQ4 2023: $131.3MQ1 2024: $114.4MQ2 2024: $119.4MQ3 2024: $117.0MQ4 2024: $202.4MQ1 2025: $190.0MQ2 2025: $198.0MQ3 2025: $179.1MQ4 2025: $202.8MQ1 2026: $93.4MQ2 2026: $133.3M
Institutions holding LFCR and their total value by quarter
QuarterHoldersValue
Q2 202698$133.3M
Q1 2026105$93.4M
Q4 2025104$202.8M
Q3 2025100$179.1M
Q2 202587$198.0M
Q1 202587$190.0M
Q4 202476$202.4M
Q3 202482$117.0M
Q2 202475$119.4M
Q1 202479$114.4M
Q4 202378$131.3M
Q3 202369$132.5M
Q2 202375$173.9M
Q1 202382$81.7M
Q4 202293$160.0M
Q3 202286$220.0M
Q2 202290$252.1M
Q1 202297$278.9M
Q4 202198$287.2M
Q3 202192$235.5M
Q2 202195$285.5M
Q1 202193$275.2M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Lifecore Biomedical, Inc. DE; share changes are against Q1 2026.

Institutions holding LFCR in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Susquehanna International Group, LLP0$00.00%−40,789−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−36,261−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−32,500−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−20,375−100.0%Sold out
SG Americas Securities, LLC0$00.00%−17,279−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−16,004−100.0%Sold out
Warberg Asset Management LLC0$00.00%−15,000−100.0%Sold out
GWN Securities Inc.0$00.00%−13,975−100.0%Sold out
nVerses Capital, LLC0$00.00%−10,027−100.0%Sold out
one8zero8, LLC0$00.00%−10,000−100.0%Sold out
Meeder Asset Management Inc0$00.00%−2,873−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−1,678−100.0%Sold out
Hurley Capital, LLC0$00.00%−1,148−100.0%Sold out
Key Financial Inc0$00.00%−1,120−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−22−100.0%Sold out
True Wealth Design, LLC0$00.00%−12−100.0%Sold out
Rothschild Investment LLC0$00.00%−5−100.0%Sold out
CWM, LLC––––Not filed
Sunbelt Securities, Inc.––––Not filed